Citation

Goodman M, Roiff T, Oakes AH, Paris J. Curr. Psychiatry Rep. 2012; 14(1): 79-85.

Affiliation

Mount Sinai School of Medicine, 130 West Kingsbridge Road, Bronx VAMC, Bronx, NY, 10468, USA, marianne.goodman@va.gov.

Copyright

(Copyright © 2012, Holtzbrinck Springer Nature Publishing Group)

DOI

10.1007/s11920-011-0249-4

PMID

22113831

Abstract

This paper reviews recent advances in our understanding of suicidality in borderline personality disorder (BPD), with a focus on suicide risk assessment, guidelines for treatment, and medicolegal concerns. Relevant material on distinctions between suicide completers and suicide attempters, contributions of published American Psychiatric Association Guidelines, the controversial role of hospitalization, and management strategies regarding litigation is addressed. Despite accumulating data on suicidality in BPD, the current state of knowledge offers only partial clues to help identify the BPD patients most at risk of death by suicide, and offers a limited armamentarium of treatment targeted to suicide prevention, creating discomfort in clinicians and fears regarding litigation in the event of a successful suicide. Promising new interventions include less resource-intensive psychotherapies as well as brief crisis intervention.

Language: en